Resources
Events
Society of Toxicology 64th Annual Meeting and ToxExpo
Join us in Orlando, FL, March 16-20, for the Society of Toxicology Annual Meeting and ToxExpo where our team will be featuring our specialized cells and models, human biospecimens, and assay services to help address critical gaps in toxicology research. You can also learn how our extensive expertise in the design of in vitro studies and interpretation of study results.
Press Releases
LifeNet Health Selected by the Henry M. Jackson Foundation to Recover Biospecimens to Study the Effects of CTE in Military Personnel
The largest Department of Defense-funded CTE scientific research project at USUHS, this study aims to advance treatment options for U.S. service members over a five-year period
Read MoreTruVivo Named Cell Biology Product of the Year
LOS ANGELES (Nov. 8, 2023) — TruVivo™, a pioneering all-human 2D+ hepatic system that supports ADME/DMPK, toxicology and disease modeling applications, has been selected as the Cell Biology Product of the Year in the second annual BioTech Breakthrough Awards program.
Read MoreLifeNet Health LifeSciences partners with CN Bio to set a new standard for cell quality and performance
Virginia Beach, Va. (Sept. 6, 2023) — Microphysiological systems hold the promise of revolutionizing compound discovery and safety testing — but only if researchers have access to high-quality, reliable 3D cells. LifeNet Health LifeSciences has been at the forefront of addressing this challenge, and recently the organization took another key step by entering into an agreement to supply and distribute hepatic cells to CN Bio, a leading organ-on-a-chip company that manufactures single- and multi-organ MPS platforms.
Read MoreLifeNet Health LifeSciences launches TruVivo, a pioneering all-human 2D+ hepatic system, to revolutionize compound discovery
Virginia Beach, Va. (April 4, 2023) – LifeNet Health LifeSciences, the leader in all-human research solutions, today launched TruVivo, a pioneering all-human cell-based liver system, to support vital drug and compound development and discovery. TruVivo is the biggest co-culture advancement in more than a decade, offering stable, reliable results - well to well, experiment to experiment, and user to user.
Read MoreLifeNet Health LifeSciences launches new, human-relevant Cell-Based Assay Service for drug and compound discovery
Virginia Beach, Va. (Aug. 1, 2022) - LifeNet Health LifeSciences, a leader in all-human biomedical research solutions, is launching a new Cell-Based Assay Service following the acquisition of biotechnology firm IONTOX. These new in vitro screening options offer alternatives to animal testing that support safer, more effective novel compound discovery – providing a new level of human relevance and predictability, while furthering LifeNet Health’s commitment to improve lives through the gift of donation.
Read MoreLifeNet Health LifeSciences will showcase innovative all-human research solutions at SOT ToxExpo
- Featuring pre-clinical research solutions to include an all-human triculture model, thyrocytes for use in 3D models, and genotyped human hepatocytes
- A series of engaging events during SOT will offer researchers opportunities to connect directly with LifeNet Health LifeSciences subject matter experts
Virginia Beach, Va.
Read MorePure MHC, LLC Announces Launch of its Peptide HLA Immunotherapy Data Resource following Collaboration with LifeNet Health
March 16, 2021
Austin, Texas, USA, March 16, 2021 -- Pure MHC, LLC, a target discovery and development company, today announced the launch of its Peptide HLA Immunotherapy Data Resource (“PHIDR”), built through its collaboration with a trusted provider of transplant solutions and a leader in regenerative medicine, LifeNet Health.
Read MoreLifeNet Health LifeSciences highlights innovative human cell- and tissue-based solutions at 2021 Society of Toxicology ToxExpo
March 12, 2021
VIRGINIA BEACH, Va. (March 12, 2021) — LifeNet Health LifeSciences will showcase its portfolio of innovative human cell- and tissue-based research solutions — including the new, all-human Tri-Culture model, thyrocytes for use in 3D models and genotyped human hepatocytes — at the Society of Toxicology (SOT) virtual annual meeting and ToxExpo at booth #1322. LifeSciences provides researchers human-relevant research solutions to optimize outcomes and speed the drug discovery process.
Read MoreLifeNet Health LifeSciences has isolated primary human lung cells to aid and accelerate efforts in COVID-19 drug development
February 3, 2021
VIRGINIA BEACH, Va. (Feb. 3, 2021) — LifeNet Health LifeSciences has successfully isolated three types of primary human lung epithelial cells from a single donor. One of the three types, alveolar epithelial type II cells, are of particular interest to scientists due to their applicability for respiratory disease research. LifeNet Health’s scientists have also isolated the bronchial and small airway epithelial cells, which are critical for the first lines of defense in protecting the lungs.
Read MoreLifeNet Health launches newly expanded LifeSciences division with innovative solutions for researchers
January 13, 2021
VIRGINIA BEACH, Va. — LifeNet Health announced today the launch of their newly expanded LifeSciences division which is offering human cell- and tissue-based research solutions through a new website, LNHLifeSciences.org.
Read More